Company Filing History:
3 out of 41 
1 out of 12 
1 out of 103 
Years Active: 2015-2025
Title: Maarten Penning: Innovator in Cancer Detection Technologies
Introduction
Maarten Penning is a notable inventor based in Sart-Tilman, Belgium. He has made significant contributions to the field of cancer detection through his innovative methods and technologies. With a total of five patents to his name, Penning's work focuses on detecting epigenetic modifications that can indicate a predisposition to cancer.
Latest Patents
Penning's latest patents include groundbreaking methods for detecting epigenetic changes in various genes associated with cancer. These methods involve analyzing samples to identify changes in genes such as NDRG4, GATA4, and others. His inventions also encompass pharmacogenetic methods that help determine suitable treatment regimens for cancer patients. Additionally, he has developed improved techniques for collecting, processing, and analyzing body fluid samples, which are crucial for diagnosing and characterizing diseases, particularly gastrointestinal cancers.
Career Highlights
Throughout his career, Maarten Penning has worked with prominent companies in the healthcare sector, including Exact Sciences Development Company and MDxHealth. His experience in these organizations has allowed him to refine his expertise in cancer diagnostics and treatment methodologies.
Collaborations
Penning has collaborated with esteemed colleagues such as Manon Van Engeland and Manon Adriaan De Bruine. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Maarten Penning's innovative work in cancer detection and treatment exemplifies the impact of scientific research on healthcare. His patents and collaborations continue to pave the way for advancements in diagnosing and treating cancer effectively.